Vilnius University, Faculty of Medicine, Lithuania.
Center for Pediatric Oncology and Hematology, Vilnius University, Lithuania.
Ginekol Pol. 2021;92(4):262-270. doi: 10.5603/GP.a2021.0027. Epub 2021 Mar 23.
Sexual dysfunction was reported to compromise the quality of life in childhood cancer survivors. The aim of our study was to evaluate the reproductive health in long-term pediatric cancer survivors by conducting a crosscut survey.
Childhood cancer survivors over 18 years of age, who were in remission for more than 5 years, were invited to complete a gender-specific questionnaire surveying on their reproductive health. Demographic and treatment data were retrieved from their medical records. Treatment modalities were reviewed for its potential gonadotoxicity.
34 (17 males and 17 females, respectively) from 346 addressed survivors (9.8%) completed the questionnaire. Median age and follow-up after diagnosis was 27 (18-35) and 14 (3-25) years, respectively. Some respondents reported sexual concerns: 11.8% males experienced problems with penetration, two males (11.8%) who underwent semen analysis were found to be azoospermic. Similarly, 11.8% females reported delayed puberty, the average age of menarche was 14 (12-17) years, 29.4% females reported irregular menstrual cycles. Cyclophosphamide equivalent dose (CED) differed significantly between the patients treated for leukemia, lymphoma and solid tumors (3000 vs 4352 vs 6660 mg/m2, respectively, p = 0.014).
Low prevalence of sexual dysfunction, fertility related disorders or delayed puberty in childhood cancer survivors was found. However, the results should be interpreted with caution taking into account a low response rate.
性障碍被报道会降低儿童癌症幸存者的生活质量。我们的研究目的是通过横断面调查评估长期儿童癌症幸存者的生殖健康。
邀请年龄超过 18 岁、缓解期超过 5 年的儿童癌症幸存者完成一份针对其生殖健康的性别特异性问卷。从病历中获取人口统计学和治疗数据。评估治疗方式对性腺毒性的潜在影响。
34 名受访者(男性 17 名,女性 17 名)完成了问卷。中位年龄和诊断后随访时间分别为 27 岁(18-35 岁)和 14 岁(3-25 岁)。一些受访者报告了性问题:11.8%的男性出现了插入困难,两名接受精液分析的男性被发现无精子症。同样地,11.8%的女性报告了青春期延迟,初潮平均年龄为 14 岁(12-17 岁),29.4%的女性报告了月经周期不规律。接受白血病、淋巴瘤和实体瘤治疗的患者的环磷酰胺等效剂量(CED)有显著差异(分别为 3000、4352 和 6660mg/m2,p=0.014)。
在儿童癌症幸存者中,性功能障碍、生育相关障碍或青春期延迟的患病率较低。然而,考虑到低应答率,结果应谨慎解释。